Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05031728
Other study ID # BritishUE20-21
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2017
Est. completion date January 1, 2021

Study information

Verified date September 2021
Source British University In Egypt
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: Studies among Syrian refugees showed high prevalence rates of PTSD. The objective of the present study was to investigate the effectiveness of Cognitive Processing Therapy (CPT) in treating patients with posttraumatic stress disorder (PTSD) using a clinical trial. Methods: Data will be obtained through interviewing patients seeking for PTSD treatment. Patients will be interviewed by a clinician and asked to complete the Clinician-Administered PTSD Scale (CAPS-5), Beck Depression Inventory (BDI-II), Beck Anxiety Inventory (BAI). Assessments will be conducted at baseline, 3-, and 12-months posttreatment. The primary outcomes will be the scores of CAPS, BDI-II, and BAI. Results: we predict that CPT will result in greater reductions in CAPS scores.


Description:

Although individuals with PTSD experience significant suffering, disability, and a challenging clinical course, there are still significant gaps in the evidence addressing effective treatment options. Therefore, in the current study CPT will determine the effectiveness in treating Syrian patients with PTSD. Current study significantly adds to the existing literature. It is a novel study in Egypt and adds to the literature.


Recruitment information / eligibility

Status Completed
Enrollment 94
Est. completion date January 1, 2021
Est. primary completion date December 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria Their nationalities are Syrians - age older than 18 years and younger than 65, - patients meeting current diagnostic criteria for PTSD as defined in DSM-5 - have a good knowledge of English-language (reading, writing, and comprehension) because all assessments and therapy materials were in English Exclusion Criteria - having mental retardation - having schizophrenia (or any other psychotic disorders).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive Processing Therapy (CPT)
Cognitive processing therapy (CPT) (Resick et al., 2016) which is a specific type of cognitive behavioral therapy that has been effective in reducing symptoms of Post-Traumatic Stress Disorder (PTSD) that may have developed after experiencing a variety of traumatic events including child abuse, emotional abuse, combat, rape war, and natural disasters. CPT helps patients learn how to challenge and modify unhelpful beliefs related to the trauma and emotional pain. In so doing, the client creates a new understanding and conceptualization of the traumatic event so that it reduces its ongoing negative effects on current life.

Locations

Country Name City State
Egypt The British university in Egypt Cairo

Sponsors (1)

Lead Sponsor Collaborator
British University In Egypt

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary assessing change in CAPS-5 scores between three time points Clinician-Administered PTSD Scale (CAPS-5; Weathers et al., 2015) is currently the gold- standard assessment for PTSD and is used to assess PTSD's symptoms at pre-intervention, immediately post- intervention, and 12-month after the intervention. This 30-item structured interview was developed by staff at the U.S. Department of Veterans Affairs National Center for PTSD. The interview can generally be administered in 45-60 minutes. Each question in CAPS asks about both the frequency and the severity of each PTSD symptom. These questions are split into categories. Each criterion has several questions, and scores for each criterion are added up at the end. The CAPS-5 has demonstrated strong psychometric properties (Weathers, et al., 2018). baseline (pre-intervention), posttreatment (immediately after the intervention), 12-months after the intervention
Secondary assessing change in Beck Depression Inventory (BDI-II) scores between three time points Beck Depression Inventory (BDI-II): was used to evaluate the change in the severity of depressive symptoms between three time points. BDI-II is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression (Beck, et al., 1996). The BDI takes approximately 10 minutes to complete. Depression levels were defined as follows: minimal range = 0- 13, mild depression = 14-19, moderate depression = 20-28, and severe depression = 29- 63. baseline (pre-intervention), posttreatment (immediately after the intervention), 12-months after the intervention
Secondary assessing change in Beck Anxiety Inventory (BAI) scores between three time points Beck Anxiety Inventory (BAI): was used to evaluate the change in the severity of anxiety severity between three time points.
BAI was developed by Dr. Aaron T. Beck and it is a brief measure of anxiety with a focus on somatic symptoms of anxiety such as nervousness, dizziness, inability to relax (Beck et al., 1988). It has a total of 21 items that takes approximately 10-15 minutes to complete. Answers are on a 4-point Likert scale and range from 0 (not at all) to 3 (severely). The values for each item are summed yielding an overall or total score for all 21 symptoms that can range between 0 and 63 points. A total score of 0 - 7 is interpreted as a "Minimal" level of anxiety; 8 - 15 as "Mild"; 16 -25 as "Moderate", and 26 - 63 as "Severe".
baseline (pre-intervention), posttreatment (immediately after the intervention), 12-months after the intervention
See also
  Status Clinical Trial Phase
Completed NCT01443182 - Treatment of Posttraumatic Stress Disorder (PTSD) in Adult Survivors of Early Chronic Interpersonal Trauma N/A
Completed NCT01507948 - Brain Imaging of Psychotherapy for Posttraumatic Stress Disorder (PTSD) N/A
Completed NCT02911285 - NAC for Treating Comorbid PTSD and SUD Phase 2
Recruiting NCT02234076 - A Study on the Efficacy of Virtual Reality Exposure Therapy (VRET) for Survivors of Childhood Sexual Abuse and War Related Trauma N/A
Completed NCT01729026 - A Study of Dog Adoption in Veterans With Posttraumatic Stress Disorder (PTSD) Early Phase 1
Completed NCT01464892 - Imagery Rescripting in the Treatment of Post Traumatic Stress Disorder (PTSD) Following Early Chronic Interpersonal Trauma N/A
Completed NCT01406834 - Treatment for the Mental Health Impact of Killing in War N/A
Completed NCT01446146 - Increasing Engagement in PTSD Treatment Through Patient Education and Patient Choice N/A
Active, not recruiting NCT03283163 - Neurobiological and Psychological Benefits of Exercise in Chronic Pain and PTSD N/A
Completed NCT02442843 - Non Invasive Brain Stimulation for PTSD Early Phase 1
Completed NCT01888653 - Attention-Bias Modification Treatment for PTSD N/A
Completed NCT01474057 - DElivery of Self Training and Education for Stressful Situations-Primary Care Version Phase 2
Completed NCT00672776 - Effects of Paxil CR on Neural Circuits in Posttraumatic Stress Disorder (PTSD) Phase 4
Completed NCT03641924 - Cognition and Psychotherapy in PTSD
Completed NCT02397889 - Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD) Phase 2/Phase 3
Completed NCT02322047 - Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders Phase 2
Completed NCT00320138 - Acupuncture for the Treatment of Posttraumatic Stress Among Military Personnel Phase 1
Recruiting NCT03833453 - Effectiveness of PTSD-treatment Compared to Integrated PTSD-PD-treatment in Adult Patients With Comorbid PTSD and BPD N/A
Completed NCT03833531 - Effectiveness of PTSD-treatment Compared to Integrated PTSD-PD-treatment in Adult Patients With Comorbid PTSD and CPD N/A
Completed NCT03529435 - Project Remission: Maximizing Outcomes With Intensive Treatments for Combat-Related PTSD N/A